Masimo | MASI - Gewinn Vor Steuern

Aktienkurs
178.24
Täglich Wechseln
-0.46 -0.26%
Monatlich
1.71%
Jährlich
7.49%
Q1 Prognose
170.19




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.36B 178M 2025-12
Accuray USD 3.23M 6.56M 2024-12
Align Technology USD 176.6M 81.86M 2025-12
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 2.36M 2.45M 2025-12
Avanos Medical USD -1.2M 74.7M 2025-09
Baxter International USD 121M 12M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 938M 3M 2025-09
Dexcom USD 300M 58.9M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
General Electric Aerospace USD 2.85B 337M 2025-12
Globus Medical USD 143.99M 44.18M 2025-09
Haemonetics USD 59.97M 8.69M 2025-12
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
Intuitive Surgical USD 855.2M 23.1M 2025-09
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Orthofix International USD -2.19M 20.07M 2025-12
Owens Minor USD 35.71M 5.37M 2025-09
ResMed USD 482.38M 2.51M 2025-09
Steris USD 324.4M 92.5M 2025-09
Stryker USD 1.03B 13M 2025-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Zimmer Biomet Holdings USD 418.7M 194.1M 2025-09